Emergent BioSolutions Inc. (NYSE:EBS) Q3 2025 Earnings Call Transcript October 29, 2025
Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is $1.06, expectations were $-0.12.
Operator: Good day, and thank you for standing by. Welcome to the Q3 2025 Emergent BioSolutions Inc. Earnings Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand your conference over to your first speaker today, Frank Vargo,...
